左心室肥厚的消退 - Suppr

Regression of left ventricular hypertrophy.

作者信息

Kawasoe Shin, Ohishi Mitsuru

机构信息

Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University Kagoshima, Kagoshima, Japan.

出版信息

Hypertens Res. 2024 May;47(5):1225-1226. doi: 10.1038/s41440-024-01634-6. Epub 2024 Mar 11.

DOI:10.1038/s41440-024-01634-6

PMID:38467796

Abstract

摘要

相似文献

Regression of left ventricular hypertrophy.左心室肥厚的消退

Hypertens Res. 2024 May;47(5):1225-1226. doi: 10.1038/s41440-024-01634-6. Epub 2024 Mar 11.

Left ventricular hypertrophy, geometric patterns and clinical correlates among treated hypertensive Nigerians.接受治疗的尼日利亚高血压患者的左心室肥厚、几何形态及临床关联

Pan Afr Med J. 2010 Mar 4;4:8. doi: 10.4314/pamj.v4i1.53602.

The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA).抗高血压治疗对高血压左心室肥厚患者经多普勒测定的心肌性能指数的影响：瑞典厄贝沙坦与阿替洛尔治疗左心室肥厚研究（SILVHIA）的结果

Echocardiography. 2009 Aug;26(7):753-8. doi: 10.1111/j.1540-8175.2008.00886.x.

Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors.黑人高血压患者的左心室肥厚：聚焦于血管紧张素转换酶抑制剂的疗效

BMC Res Notes. 2014 Jan 20;7:45. doi: 10.1186/1756-0500-7-45.

[Aging and regression of cardiac hypertrophy in the hypertensive patient].[高血压患者心脏肥大的衰老与消退]

Rev Med Interne. 1998 Dec;19(12):870-7. doi: 10.1016/s0248-8663(99)80059-9.

Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients.伊拉地平对既往未治疗的高血压患者左心室肥厚的消退作用

Am J Hypertens. 1993 Mar;6(3 Pt 2):86S-88S. doi: 10.1093/ajh/6.3.86s.

Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.抗高血压治疗期间左心室结构和功能的性别差异：氯沙坦降低高血压终点事件干预研究

Hypertension. 2008 Apr;51(4):1109-14. doi: 10.1161/HYPERTENSIONAHA.107.107474. Epub 2008 Feb 7.

[Can pathological left ventricular hypertrophy in arterial hypertension be distinguished from physiological hypertrophy caused by sports?].[动脉高血压所致的病理性左心室肥厚能否与运动引起的生理性肥厚相鉴别？]

Dtsch Med Wochenschr. 2001 Mar 9;126(10):263-7. doi: 10.1055/s-2001-11739.

Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.尼群地平与卡托普利治疗原发性高血压：对昼夜血压及左心室肥厚的影响。

Cardiology. 1994;85(2):101-10. doi: 10.1159/000176657.

Regression of left ventricular hypertrophy in hypertension--does it reduce cardiovascular risk?高血压患者左心室肥厚的消退——它能降低心血管风险吗？

Rev Port Cardiol. 2005 Jul-Aug;24(7-8):1007-13.

引用本文的文献

Ambulatory blood pressure monitoring and left ventricular morphology.动态血压监测与左心室形态

Hypertens Res. 2025 Jan;48(1):417-419. doi: 10.1038/s41440-024-01993-0. Epub 2024 Nov 7.

本文引用的文献

Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential.心脏肥大在健康和疾病中的消退：机制和治疗潜力。

Nat Rev Cardiol. 2023 May;20(5):347-363. doi: 10.1038/s41569-022-00806-6. Epub 2023 Jan 4.

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。

N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial.达格列净对 2 型糖尿病患者左心室肥厚的随机对照临床试验：DAPA-LVH 试验。

Eur Heart J. 2020 Sep 21;41(36):3421-3432. doi: 10.1093/eurheartj/ehaa419.

Is Left Ventricular Hypertrophy a Valid Therapeutic Target?左心室肥厚是否为有效的治疗靶点？

Curr Hypertens Rep. 2019 May 20;21(6):47. doi: 10.1007/s11906-019-0952-9.

The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction.沙库巴曲缬沙坦治疗射血分数降低的心力衰竭的逆重构反应。

Cardiovasc Ther. 2018 Aug;36(4):e12435. doi: 10.1111/1755-5922.12435. Epub 2018 Jun 7.

Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).门诊诊所（坎帕尼亚健康网络）抗高血压治疗期间左心室肥厚的逆转

J Am Heart Assoc. 2017 Mar 8;6(3):e004152. doi: 10.1161/JAHA.116.004152.

Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.心电图左心室肥厚或劳损的消退与高血压患者心血管疾病发病率和死亡率的降低相关，且独立于血压降低—— LIFE研究综述

J Electrocardiol. 2014 Sep-Oct;47(5):630-5. doi: 10.1016/j.jelectrocard.2014.07.003. Epub 2014 Jul 3.

Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.抗高血压治疗使左心室质量消退：随机对照研究的荟萃分析

Hypertension. 2009 Nov;54(5):1084-91. doi: 10.1161/HYPERTENSIONAHA.109.136655. Epub 2009 Sep 21.

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.降压治疗期间心电图左心室肥厚的消退与心源性猝死的减少：LIFE研究

Circulation. 2007 Aug 14;116(7):700-5. doi: 10.1161/CIRCULATIONAHA.106.666594. Epub 2007 Jul 30.

Prognostic significance of serial changes in left ventricular mass in essential hypertension.原发性高血压患者左心室质量的系列变化的预后意义

Circulation. 1998;97(1):48-54. doi: 10.1161/01.cir.97.1.48.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Regression of left ventricular hypertrophy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献